Trial Profile
Phase I trial of weekly nab-paclitaxel plus cyclophosphamide for metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide
- Indications Adenocarcinoma; Advanced breast cancer
- Focus Adverse reactions
- 01 Dec 2019 Results published in the Anticancer Research
- 14 Dec 2016 Status changed from recruiting to completed.
- 28 Jun 2013 New trial record